The intersection of personalized cardiology and precision medicine offers a new frontier in the treatment of heart conditions. Through the use of genomic data, personalized cardiology allows for customized treatment plans that focus on an individual’s genetic predispositions and lifestyle factors. This level of individualized care ensures that patients receive therapies that are specifically suited to their needs, reducing the trial-and-error approach often seen in traditional medicine. By leveraging precision medicine, cardiologists can now predict how patients will respond to specific treatments, offering a more effective, proactive approach to managing cardiovascular diseases and improving patient outcomes.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States